11-8413553-T-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001352389.2(STK33):āc.1286A>Cā(p.Gln429Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000598 in 1,614,088 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001352389.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
STK33 | NM_001352389.2 | c.1286A>C | p.Gln429Pro | missense_variant | 15/16 | ENST00000687296.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
STK33 | ENST00000687296.1 | c.1286A>C | p.Gln429Pro | missense_variant | 15/16 | NM_001352389.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000421 AC: 64AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000422 AC: 106AN: 251450Hom.: 0 AF XY: 0.000412 AC XY: 56AN XY: 135902
GnomAD4 exome AF: 0.000616 AC: 901AN: 1461782Hom.: 1 Cov.: 32 AF XY: 0.000582 AC XY: 423AN XY: 727192
GnomAD4 genome AF: 0.000420 AC: 64AN: 152306Hom.: 0 Cov.: 32 AF XY: 0.000497 AC XY: 37AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2022 | The c.1286A>C (p.Q429P) alteration is located in exon 13 (coding exon 11) of the STK33 gene. This alteration results from a A to C substitution at nucleotide position 1286, causing the glutamine (Q) at amino acid position 429 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | STK33: BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at